technescan dtpa -
curium netherlands b.v. - kalsiumtrinatriumpentetat - preparasjonssett til radioaktive legemidler
technescan hdp -
curium netherlands b.v. - natriumoksidronat - preparasjonssett til radioaktive legemidler
ultra technekow fm -
curium netherlands b.v. - natriummolybdat mo-99 omdannet til natriumperteknetat tc-99m - radionuklidegenerator
venticoll 0.5 mg
ge healthcare as - albumin, humant, kolloidale partikler - pulver til inhalasjonsvæske til nebulisator, oppløsning - 0.5 mg
divifarm 800 iu
orifarm generics a/s - kolekalsiferol - tablett, filmdrasjert - 800 iu
fulvestrant medical valley 250 mg
medical valley invest ab - fulvestrant - injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 250 mg
pemazyre
incyte biosciences distribution b.v. - pemigatinib - cholangiocarcinoma - antineoplastiske midler - pemazyre monotherapy is indicated for the treatment of adults with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.
faslodex 250 mg/5 ml
paranova as (1) - fulvestrant - injeksjonsvæske, oppløsning - 250 mg/5 ml
fulvestrant sun 250 mg
sun pharmaceutical - nederland - fulvestrant - injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 250 mg
rybrevant
janssen-cilag international n.v. - amivantamab - karsinom, ikke-småcellet lunge - antineoplastiske midler - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.